Somatropin Injection Human Growth Hormone for Pediatric Growth Disorders in 3ml Cartridge Refrigerated 2-8°C

Product Description:

Somatropin Injection is a medically formulated preparation designed to address various growth-related disorders by supplementing the body's natural levels of human growth hormone. Available in various strengths, including 5 mg and 10 mg per vial, this product provides flexible dosing options to meet individual patient needs. The injection is typically administered using a convenient 3ml cartridge compatible with a specialized injection pen, ensuring precise and comfortable delivery.

This product is primarily indicated for the treatment of Growth Hormone Deficiency in both children and adults, a condition where the body fails to produce adequate amounts of growth hormone, leading to impaired growth and development. Additionally, Somatropin Injection is prescribed for Turner Syndrome, a genetic disorder affecting females that results in short stature and other developmental challenges. Patients with Chronic Kidney Disease who experience growth failure may also benefit from this therapy, as well as those diagnosed with Prader-Willi Syndrome, a complex genetic condition characterized by poor muscle tone, low levels of human growth hormone, and developmental delays.

The mechanism of action of Somatropin Injection involves stimulating growth and cell reproduction by mimicking the effects of natural human growth hormone produced by the pituitary gland. This synthetic hormone binds to specific receptors on target cells, promoting protein synthesis, increasing muscle mass, and encouraging bone growth. By replicating the physiological actions of endogenous growth hormone, Somatropin Injection effectively supports normal growth patterns and metabolic functions in affected individuals.

Somatropin Injection is formulated to be administered via subcutaneous injection using a 3ml cartridge inserted into an injection pen, which allows for accurate dosing and ease of use. This delivery method enhances patient compliance and convenience, particularly for long-term treatment regimens. The injection pen is designed for multiple uses, providing a user-friendly interface that reduces discomfort and simplifies the administration process.

Despite its therapeutic benefits, Somatropin Injection is contraindicated in certain conditions. It should not be used in patients with active malignancy, as growth hormone may potentially stimulate tumor growth. Similarly, individuals experiencing acute critical illness, particularly those with complications following surgery, trauma, or respiratory failure, should avoid this treatment due to increased risk of adverse outcomes. Furthermore, patients with known hypersensitivity to somatropin or any of the injection components must not receive this medication to prevent allergic reactions.

In conclusion, Somatropin Injection serves as a vital human growth hormone replacement therapy for patients suffering from a variety of growth disorders, including Growth Hormone Deficiency, Turner Syndrome, Chronic Kidney Disease-related growth failure, and Prader-Willi Syndrome. Its ability to mimic natural growth hormone actions makes it an effective solution for stimulating growth and cellular reproduction. Available in multiple strengths and delivered via a 3ml cartridge injection pen, it offers both efficacy and convenience. However, careful consideration of contraindications such as active malignancy, acute critical illness, and hypersensitivity is essential to ensure safe and appropriate use.

Features:

• Product Name: Somatropin Injection
• Strength: Various Strengths Available (e.g., 5 Mg, 10 Mg Per Vial)
• Active Ingredient: Somatropin, a form of human growth hormone (hgh)
• Administration Route: Subcutaneous or Intramuscular injection
• Can be used with an injection pen for convenient dosing
• Shelf Life: Typically 24 months

Technical Parameters:

Applications:

The Delfu Somatropin Injection, model number BZ-18, is a high-quality recombinant human growth hormone (hgh) product originating from China. It is designed for use in various medical scenarios where growth hormone therapy is indicated. Available in various strengths, such as 5 mg and 10 mg per vial, this hgh injection is supplied in a convenient 3ml cartridge form, facilitating precise dosage and ease of administration.

This hgh injection is primarily used in the treatment of growth hormone deficiency in both children and adults. It helps stimulate growth in pediatric patients with inadequate endogenous growth hormone production, promoting height increase and overall development. In adults, Somatropin is used to address conditions such as adult growth hormone deficiency, which can lead to decreased muscle mass, increased fat accumulation, and impaired quality of life.

The administration route for Delfu Somatropin Injection is either subcutaneous or intramuscular, depending on the patient's needs and physician's recommendations. The injection is typically administered daily, allowing for steady absorption and effective therapeutic outcomes. The 3ml cartridge design ensures that healthcare providers and patients can accurately measure the required dosage, minimizing the risk of errors.

Somatropin Injection is also applicable in scenarios such as Turner syndrome, chronic kidney disease-related growth failure, and Prader-Willi syndrome. It supports improved growth and metabolic functions in these conditions when used as part of a comprehensive treatment plan.

However, certain contraindications must be observed. Delfu Somatropin Injection should not be used in patients with active malignancy, acute critical illness, or hypersensitivity to somatropin or any of its components. Careful patient evaluation and monitoring are essential to ensure safety and efficacy during therapy.

Overall, the Delfu Somatropin Injection BZ-18 model offers a reliable and effective hgh treatment option in various clinical occasions, leveraging its recombinant human growth hormone classification and versatile dosing strengths. Its subcutaneous or intramuscular administration routes and convenient 3ml cartridge format make it suitable for diverse therapeutic scenarios requiring growth hormone replacement or supplementation.

Customization:

Introducing the Delfu Somatropin Injection, model number BZ-18, a high-quality hgh product originating from China. This 3ml cartridge is designed to effectively treat conditions such as Growth Hormone Deficiency, Turner Syndrome, Chronic Kidney Disease, and Prader-Willi Syndrome.

Our Somatropin Injection works by stimulating growth and cell reproduction, mimicking the action of natural growth hormone to promote overall development and health. Each 3ml cartridge ensures precise dosing and convenience for patients requiring growth hormone therapy.

For optimal efficacy, store the product under recommended conditions: refrigerate at 2-8°C and do not freeze. Common side effects may include injection site reactions, headache, edema, and muscle pain.

Choose the Delfu Somatropin Injection 3ml cartridge for reliable and effective hgh treatment tailored to your needs.

Support and Services:

For Product Technical Support and Services related to Somatropin Injection, please refer to the detailed product information leaflet provided with your medication. Ensure that Somatropin Injection is stored and handled according to the guidelines to maintain its efficacy. In case of any adverse reactions or if you require assistance with dosage or administration techniques, consult your healthcare provider promptly. For further technical support, refer to the official product documentation or reach out to authorized medical professionals who can provide specialized guidance and services.